stars 1 stars 2 stars 3

ProSys is a leading provider of isolator technology and sampling systems to the bio-pharmaceutical market We design and manufacture EtO - ‘Engineered to Order’ - isolators for aseptic processing in ISO5 environments and for the management of highly potent compound handling to OEB5 & 6 levels. We also design and build liquid, gas and powder sampling systems for industry including toxic applications and for high pressure, viscous and low volume sampling. A focus on 'Customer Intimacy', design flexibility, equipment quality and delivery assurance has been the corner-stone of our growth and development since we were founded in 1997. We operate globally with local in-market technical and after sales service support to serve our client base drawn from the Clinical, R&D, Manufacturing and Consultancy sectors

ProSys Group Questions

The ProSys Group annual revenue was $65.6 million in 2026.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users